145 related articles for article (PubMed ID: 21105783)
21. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions.
Vickers AE; Sinclair JR; Zollinger M; Heitz F; Glänzel U; Johanson L; Fischer V
Drug Metab Dispos; 1999 Sep; 27(9):1029-38. PubMed ID: 10460803
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of α-thujone in human hepatic preparations in vitro.
Abass K; Reponen P; Mattila S; Pelkonen O
Xenobiotica; 2011 Feb; 41(2):101-11. PubMed ID: 21087116
[TBL] [Abstract][Full Text] [Related]
23. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
24. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
[TBL] [Abstract][Full Text] [Related]
25. Interaction of cisapride with the human cytochrome P450 system: metabolism and inhibition studies.
Desta Z; Soukhova N; Mahal SK; Flockhart DA
Drug Metab Dispos; 2000 Jul; 28(7):789-800. PubMed ID: 10859153
[TBL] [Abstract][Full Text] [Related]
26. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
[TBL] [Abstract][Full Text] [Related]
27. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
[TBL] [Abstract][Full Text] [Related]
28. Identification of human cytochrome P450 isozymes involved in the metabolism of naftopidil enantiomers in vitro.
Zhu L; Liu X; Zhu L; Zhang X; Fu X; Huang J; Yuan M
J Pharm Pharmacol; 2014 Nov; 66(11):1534-51. PubMed ID: 24944083
[TBL] [Abstract][Full Text] [Related]
29. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.
Fischer V; Johanson L; Heitz F; Tullman R; Graham E; Baldeck JP; Robinson WT
Drug Metab Dispos; 1999 Mar; 27(3):410-6. PubMed ID: 10064574
[TBL] [Abstract][Full Text] [Related]
30. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
Fischer V; Vickers AE; Heitz F; Mahadevan S; Baldeck JP; Minery P; Tynes R
Drug Metab Dispos; 1994; 22(2):269-74. PubMed ID: 8013282
[TBL] [Abstract][Full Text] [Related]
31. Role of human hepatic cytochrome P-450s in territrem A metabolism.
Peng FC; Tseng HY; Tsai JC; Lin C; Doehmer J
J Toxicol Environ Health A; 2003 Jul; 66(13):1237-48. PubMed ID: 12851121
[TBL] [Abstract][Full Text] [Related]
32. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
[TBL] [Abstract][Full Text] [Related]
33. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N
Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126
[TBL] [Abstract][Full Text] [Related]
34. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.
Fang J; Coutts RT; McKenna KF; Baker GB
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):592-9. PubMed ID: 9840430
[TBL] [Abstract][Full Text] [Related]
35. Identification of human cytochrome P450 isoforms and esterases involved in the metabolism of mirabegron, a potent and selective β3-adrenoceptor agonist.
Takusagawa S; Yajima K; Miyashita A; Uehara S; Iwatsubo T; Usui T
Xenobiotica; 2012 Oct; 42(10):957-67. PubMed ID: 22509825
[TBL] [Abstract][Full Text] [Related]
36. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
[TBL] [Abstract][Full Text] [Related]
37. Studies on metabolites and metabolic pathways of bulleyaconitine A in rat liver microsomes using LC-MS(n) combined with specific inhibitors.
Bi Y; Zhuang X; Zhu H; Song F; Liu Z; Liu S
Biomed Chromatogr; 2015 Jul; 29(7):1027-34. PubMed ID: 25425064
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human cytochrome p450 enzymes involved in the metabolism of cilostazol.
Hiratsuka M; Hinai Y; Sasaki T; Konno Y; Imagawa K; Ishikawa M; Mizugaki M
Drug Metab Dispos; 2007 Oct; 35(10):1730-2. PubMed ID: 17646278
[TBL] [Abstract][Full Text] [Related]
39. Effects of cytochrome P450 inhibitors and inducers on the metabolism and pharmacokinetics of ospemifene.
Lehtinen T; Tolonen A; Turpeinen M; Uusitalo J; Vuorinen J; Lammintausta R; Pelkonen O; Scheinin M
Biopharm Drug Dispos; 2013 Oct; 34(7):387-95. PubMed ID: 23852652
[TBL] [Abstract][Full Text] [Related]
40. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes.
Sun SY; Wang YQ; Li LP; Wang L; Zeng S; Zhou H; Jiang HD
Chirality; 2013 Jan; 25(1):43-7. PubMed ID: 23001793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
